Veradermics MANE Operating Income
Operating Income at other companies
Other financials
Where this comes from
Reported directly by Veradermics in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: Veradermics ’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Veradermics 's operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Veradermics 's operating income?
- Veradermics (MANE) reported operating income of -$29.86M in Q1 2026.
- How has Veradermics 's operating income changed year-over-year?
- Veradermics 's operating income decreased by 131.2% year-over-year, from -$12.92M to -$29.86M.
- What does operating income mean?
- The profit or loss from core business activities.
- How do you interpret operating income?
- A move toward positive operating income indicates a transition toward commercial viability and operational self-sufficiency.
- How does operating income compare across companies?
- Most pre-revenue biotech companies report negative operating income as they prioritize product development over immediate profitability.